Hepatitis B and C patients more likely to develop Parkinson's disease, study finds
Can't see this email? View it online
   
  April 18, 2017  
  Parkinson's Disease  
  The latest Parkinson's disease news from News Medical  
 Hepatitis B and C patients more likely to develop Parkinson's disease, study findsHepatitis B and C patients more likely to develop Parkinson's disease, study finds
 
The viruses hepatitis B and C may both be associated with an increased risk of Parkinson's disease, according to a study published in the March 29, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The hepatitis virus affects the liver.
 
 
 MPA approves Renishaw study into chronic drug delivery system in Parkinson's patientsMPA approves Renishaw study into chronic drug delivery system in Parkinson's patients
 
The Medicines Agency of Sweden, MPA, has authorised Herantis Pharma Plc and Renishaw plc’s randomised, placebo-controlled Phase 1-2 clinical study, for the investigation of Cerebral Dopamine Neurotrophic Factor (CDNF) and Renishaw’s chronic drug delivery system, in Parkinson’s patients.
 
   Cell cultures in petri dishes open new doors to brain researchCell cultures in petri dishes open new doors to brain research
 
The most complex organ in humans is the brain. Due to its complexity and, of course, for ethical reasons, it is extremely difficult to do scientific experiments on it - ones that could help us to understand neurodegenerative diseases like Parkinson's, for example.
 
 New study finds link between neural tube defects in infants and neurodegenerative diseases
 
New study finds link between neural tube defects in infants and neurodegenerative diseasesA new study has found a link between neurological birth defects in infants commonly found in pregnant women with diabetes and several neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases.
 
 
 New NSF Industry/University Cooperative Research Center to focus on developing neural technologies
 
New NSF Industry/University Cooperative Research Center to focus on developing neural technologiesNeurological disorders like Parkinson's, the aftermath of stroke, limb loss and paralysis significantly diminish the length and quality of life -- affecting about one in six people worldwide.